These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8559095)

  • 1. Aminoglycoside dosing: one, two or three times a day?
    McLean AJ; Ioannides-Demos LL; Spicer WJ; Christophidis N
    Med J Aust; 1996 Jan; 164(1):39-42. PubMed ID: 8559095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.
    Prins JM; Weverling GJ; de Blok K; van Ketel RJ; Speelman P
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2494-9. PubMed ID: 8913452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J; Nevitt SJ
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD002009. PubMed ID: 28349527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily versus multiple-daily dosing of aminoglycosides.
    Craig WA
    J Chemother; 1995 Jun; 7 Suppl 2():47-52. PubMed ID: 8622110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J
    Cochrane Database Syst Rev; 2012 Feb; (2):CD002009. PubMed ID: 22336782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.
    Rao SC; Ahmed M; Hagan R
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005091. PubMed ID: 16437518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?
    Barclay ML; Kirkpatrick CM; Begg EJ
    Clin Pharmacokinet; 1999 Feb; 36(2):89-98. PubMed ID: 10092956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenging conventional aminoglycoside dosing regimens. The value of experimental models.
    Kapusnik JE; Sande MA
    Am J Med; 1986 Jun; 80(6B):179-81. PubMed ID: 3089001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis.
    Nestaas E; Bangstad HJ; Sandvik L; Wathne KO
    Arch Dis Child Fetal Neonatal Ed; 2005 Jul; 90(4):F294-300. PubMed ID: 15857879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single daily dose therapy with aminoglycosides.
    Nordström L; Lerner SA
    J Hosp Infect; 1991 Jun; 18 Suppl A():117-29. PubMed ID: 1679774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily aminoglycoside dosing: An update on current literature.
    Stankowicz MS; Ibrahim J; Brown DL
    Am J Health Syst Pharm; 2015 Aug; 72(16):1357-64. PubMed ID: 26246292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
    Koo J; Tight R; Rajkumar V; Hawa Z
    Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J
    Cochrane Database Syst Rev; 2014 Feb; (2):CD002009. PubMed ID: 24497229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.
    Periti P
    J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of dosing regimens and combination effects of aminoglycosides and beta-lactam in an experimental Pseudomonas aeruginosa infection in mice].
    Kikuchi K
    Kansenshogaku Zasshi; 1991 Feb; 65(2):216-25. PubMed ID: 2066605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J
    Cochrane Database Syst Rev; 2010 Jan; (1):CD002009. PubMed ID: 20091528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Tan KH
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002009. PubMed ID: 16855982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.
    Rybak MJ; Abate BJ; Kang SL; Ruffing MJ; Lerner SA; Drusano GL
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1549-55. PubMed ID: 10390201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.